Internal Medicine, Rheumatology · Hillsboro, OR
NPI
1871706218
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
545 SE Oak St Ste F
Hillsboro, OR, 97123
Phone (971) 228-8855
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.0M
132,499 services
Medicare patients, 2024
428
Average age 72
Drug cost, 2024
$6.4M
3,821 prescriptions
Company payments, 2025
$25K
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shawn G Macalester was code J3262 (injection, tocilizumab, 1 mg), 55,000 times for 22 patients. In total Shawn G Macalester billed 132,499 services in 52 codes, and Medicare paid $2.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 55,000 | 22 | $4.53 | $249K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 16,450 | 36 | $9.05 | $149K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 11,075 | 32 | $32.51 | $360K |
| J9312 Injection, rituximab, 10 mg | Office | 3,150 | 16 | $61.19 | $193K |
| J0897 Injection, denosumab, 1 mg | Office | 2,160 | 30 | $20.58 | $44K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 2,100 | 12 | $24.86 | $52K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 914 | 20 | $0.22 | $203 |
| 99214 Office E&M - Established | Office | 439 | 266 | $88.31 | $39K |
| 96413 Chemotherapy Administration | Office | 349 | 90 | $96.63 | $34K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 274 | 215 | $12.24 | $3,355 |
| 96365 Intravenous Infusion, Hydration | Office | 152 | 52 | $51.47 | $7,823 |
| 96415 Chemotherapy Administration | Office | 151 | 34 | $21.91 | $3,309 |
| 99213 Office E&M - Established | Office | 140 | 106 | $64.05 | $8,967 |
| 96401 Chemotherapy Administration | Office | 86 | 22 | $54.41 | $4,679 |
| 96375 Injection Administration | Office | 70 | 29 | $11.80 | $826 |
By year: 2022 $3.5M for 135,346 services; 2023 $2.3M for 113,579 services; 2024 $2.0M for 132,499 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 19 | 17 | $8.40 | $160 |
Medicare prescription drug claims, 2024
In 2024, the drug Shawn G Macalester prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 864 prescriptions and refills. In total Shawn G Macalester wrote 3,821 Medicare prescriptions that cost $6.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 864 | 2,109 | 285 | $23K |
| Hydroxychloroquine Sulfate Generic | 529 | 1,289 | 154 | $17K |
| Prednisone Generic | 384 | 846 | 137 | $4,710 |
| Allopurinol Generic | 178 | 492 | 48 | $2,204 |
| Celecoxib Generic | 142 | 245 | 49 | $2,856 |
| Methylprednisolone Generic | 141 | 209 | 52 | $1,640 |
| Folic Acid Generic | 109 | 314 | 46 | $975 |
| Sulfasalazine Generic | 98 | 241 | 30 | $4,542 |
| Methotrexate Sodium Methotrexate Sodium/Pf | 77 | 131 | 25 | $1,241 |
| Otezla Apremilast | 75 | 75 | Under 11 | $333K |
| Orencia Clickject Abatacept | 65 | 65 | Under 11 | $390K |
| Enbrel Sureclick Etanercept | 65 | 65 | Under 11 | $487K |
| Leflunomide Generic | 64 | 178 | 24 | $3,387 |
| Diclofenac Sodium Generic | 58 | 85 | 14 | $1,346 |
| Mycophenolate Mofetil Generic | 56 | 108 | 13 | $5,840 |
Brand drugs: 1,001 claims; generic drugs: 2,808 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shawn G Macalester $25K ($25K in general payments such as food, travel and fees) from 23 companies. The largest payer was Janssen Biotech, Inc. with $12K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 31 | $12K |
| Abbvie Inc. ABBV | 38 | $7,057 |
| Lilly USA, LLC LLY | 4 | $1,525 |
| Sobi, Inc SOBI.ST | 5 | $1,486 |
| Amgen Inc. AMGN | 28 | $1,016 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $460 |
| Mallinckrodt Hospital Products Inc. | 4 | $198 |
| UCB, Inc. UCB.BR | 9 | $192 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $161 |
| Genzyme Corporation SNY | 3 | $123 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.